{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:52:57Z","timestamp":1786981977505,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s11596-019-2055-x","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T03:02:42Z","timestamp":1560740562000},"page":"431-436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response"],"prefix":"10.1007","volume":"39","author":[{"given":"Zhuo-ni","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-li","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-ming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,17]]},"reference":[{"key":"2055_CR1","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/humrep\/dem426","volume":"23","author":"Thessaloniki, Eshre Asrm-Sponsored Pcos Consensus Workshop Group.","year":"2008","unstructured":"Thessaloniki, Eshre Asrm-Sponsored Pcos Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod, 2008,23:462\u2013477","journal-title":"Hum Reprod"},{"issue":"1","key":"2055_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5694\/mja11.10553","volume":"196","author":"JA Boyle","year":"2012","unstructured":"Boyle JA, Cunningham J, O\u2019Dea K, et al. Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia. Med J Aust, 2012,196(1):62\u201366","journal-title":"Med J Aust"},{"issue":"16","key":"2055_CR3","first-page":"2185","volume":"123","author":"Y Ma","year":"2010","unstructured":"Ma Y, Li R, Qiao J, et al. Characteristics of abnormal menstrual cycle and polycystic ovary syndrome in community and hospital populations. Chin Med J, 2010,123(16):2185\u20132189","journal-title":"Chin Med J"},{"issue":"1","key":"2055_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group.","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod, 2004,19(1):41\u201347","journal-title":"Hum Reprod"},{"issue":"6","key":"2055_CR5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/humupd\/dmw025","volume":"22","author":"AH Balen","year":"2016","unstructured":"Balen AH, Morley LC, Misso M, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update, 2016,22(6):687\u2013708","journal-title":"Hum Reprod Update"},{"issue":"1","key":"2055_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","volume":"104","author":"Y Kuang","year":"2015","unstructured":"Kuang Y, Chen Q, Fu Y, et al. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril, 2015,104(1):62\u201370.e3","journal-title":"Fertil Steril"},{"issue":"1","key":"2055_CR7","first-page":"11","volume":"83","author":"I Crha","year":"2018","unstructured":"Crha I, Ventruba P, Filipinsk\u00e1 E, et al. Medroxy-progesteron acetate use to block LH surge in oocyte donor stimulation. Ceska Gynekol, 2018,83(1):11\u201316","journal-title":"Ceska Gynekol"},{"issue":"1","key":"2055_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.fertnstert.2013.09.007","volume":"101","author":"Y Kuang","year":"2014","unstructured":"Kuang Y, Hong Q, Chen Q, et al. Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization\/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles. Fertil Steril, 2014,101(1):105\u2013111","journal-title":"Fertil Steril"},{"issue":"9","key":"2055_CR9","doi-asserted-by":"publisher","first-page":"e2939","DOI":"10.1097\/MD.0000000000002939","volume":"95","author":"Y Wang","year":"2016","unstructured":"Wang Y, Chen Q, Wang N, et al. Controlled Ovarian Stimulation Using Medroxyprogesterone Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for IVF: A Double-Blind Randomized Crossover Clinical Trial. Medicine (Baltimore), 2016,95(9):e2939","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"2055_CR10","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/humrep\/der037","volume":"26","author":"Alpha Scientists in Reproductive MedicineESHRE Special Interest Group of Embryology.","year":"2011","unstructured":"Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod, 2011,26(6):1270\u20131283","journal-title":"Hum Reprod"},{"issue":"4","key":"2055_CR11","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.fertnstert.2004.03.055","volume":"82","author":"DW Schmidt","year":"2004","unstructured":"Schmidt DW, Maier DB, Nulsen JC, et al. Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization. Fertil Steril, 2004,82(4):841\u2013846","journal-title":"Fertil Steril"},{"issue":"2","key":"2055_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3109\/19396368.2011.646047","volume":"58","author":"Z Xiao","year":"2012","unstructured":"Xiao Z, Zhou X, Xu W, et al. Natural cycle is superior to hormone replacement therapy cycle for vitrificated-preserved frozen-thawed embryo transfer. Syst Biol Reprod Med, 2012,58(2):107\u2013112","journal-title":"Syst Biol Reprod Med"},{"issue":"1","key":"2055_CR13","first-page":"CD012103","volume":"23","author":"S Mourad","year":"2017","unstructured":"Mourad S, Brown J, Farquhar C. Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews. Cochrane Database Syst Rev, 2017,23,1:CD012103","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2055_CR14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.fertnstert.2017.09.020","volume":"109","author":"M Toftager","year":"2018","unstructured":"Toftager M, Sylvest R, Schmidt L, et al. Quality of life and psychosocial and physical well-being among 1,023 women during their first assisted reproductive technology treatment: secondary outcome to a randomized controlled trial comparing gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist protocols. Fertil Steril, 2018,109(1):154\u2013164","journal-title":"Fertil Steril"},{"issue":"2","key":"2055_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/humrep\/dex367","volume":"33","author":"S Yu","year":"2018","unstructured":"Yu S, Long H, Chang HY, et al. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF\/ICSI cycles. Hum Reprod, 2018,33(2):229\u2013237","journal-title":"Hum Reprod"},{"issue":"34","key":"2055_CR16","doi-asserted-by":"publisher","first-page":"e11906","DOI":"10.1097\/MD.0000000000011906","volume":"97","author":"N Wang","year":"2018","unstructured":"Wang N, Lin J, Zhu Q, et al. Comparison of neonatal outcomes and live-birth defects after progestin-primed ovarian stimulation versus conventional ovarian stimulation for in vitro fertilization: A large retrospective cohort study. Medicine (Baltimore), 2018,97(34):e11906","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"2055_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.fertnstert.2016.10.030","volume":"107","author":"X Zhu","year":"2017","unstructured":"Zhu X, Ye H, Fu Y. Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a \u201cfreeze all\u201d strategy: a randomized controlled dose-finding study of 100 mg versus 200 mg. Fertil Steril, 2017,107(2):379\u2013386.e4","journal-title":"Fertil Steril"},{"issue":"1","key":"2055_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12958-017-0291-0","volume":"15","author":"Q Chen","year":"2017","unstructured":"Chen Q, Wang Y, Sun L, et al. Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders. Reprod Biol Endocrinol, 2017,15(1):71","journal-title":"Reprod Biol Endocrinol"},{"issue":"9","key":"2055_CR19","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3109\/09513590.2014.920002","volume":"30","author":"O Yucel","year":"2014","unstructured":"Yucel O, Ekin M, Cengiz H, et al. Comparison of estradiol and progesterone priming\/antagonist\/letrozole and microdose flare-up protocols for poor responders undergoing intracytoplasmic sperm injection. Gynecol Endocrinol, 2014,30(9):653\u2013656","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"2055_CR20","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.fertnstert.2015.01.045","volume":"103","author":"M Roque","year":"2015","unstructured":"Roque M, Valle M, Guimar\u00e3es F, et al. Freeze-all policy: fresh vs. frozen-thawed embryo transfer. Fertil Steril, 2015,103(5):1190\u20131193","journal-title":"Fertil Steril"},{"issue":"20","key":"2055_CR21","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1002\/pmic.201400145","volume":"14","author":"Y Meng","year":"2014","unstructured":"Meng Y, Guo Y, Qian Y, et al. Effects of GnRH antagonist on endometrial protein profiles in the window of implantation. Proteomics, 2014,14(20):2350\u20132359","journal-title":"Proteomics"},{"issue":"4","key":"2055_CR22","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.fertnstert.2007.07.1354","volume":"90","author":"G Griesinger","year":"2008","unstructured":"Griesinger G, Venetis CA, Marx T, et al. Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis. Fertil Steril, 2008,90(4):1055\u20131063","journal-title":"Fertil Steril"},{"issue":"2","key":"2055_CR23","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/humrep\/des389","volume":"28","author":"HM Fatemi","year":"2013","unstructured":"Fatemi HM, Doody K, Griesinger G, et al. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol. Hum Reprod, 2013,28(2):442\u2013452","journal-title":"Hum Reprod"},{"issue":"6","key":"2055_CR24","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.fertnstert.2017.10.013","volume":"108","author":"E Bosch","year":"2017","unstructured":"Bosch E, Labarta E, Pellicer A. Does cumulative live birth plateau beyond a certain ovarian response? Fertil Steril, 2017,108(6):943","journal-title":"Fertil Steril"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-019-2055-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-019-2055-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-019-2055-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T19:15:22Z","timestamp":1592248522000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-019-2055-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["2055"],"URL":"https:\/\/doi.org\/10.1007\/s11596-019-2055-x","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"14 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}